PhRMA revises principles to increase transparency
Following calls for increased transparency PhRMA has published its new clinical trial principles, which contain revisions relating to registration, authors and sponsor disclosure.
Archives for April 20, 2009
GSK to buy Stiefel for $2.93bn
GlaxoSmithKline’s (GSK) $2.9bn (€1.8bn) cash acquisition of US skin drug specialist Stiefel Laboratories “re-energises” the UK firm’s dermatology range, according to CEO Andrew Witty.
Aoxing’s pain drug plant gets GMP OK
China Aoxing Pharmaceutical, a specialist developer of pain management drugs, has received GMP accreditation for the new tablet production and packaging plant it has set up in Shijiazhuang.
Sanofi investment targets China’s diabetes market
Sanofi-Aventis is investing a further $90m in its Chinese manufacturing facility and performing “the world’s largest diabetes genotyping project” in partnership with the Chinese Diabetes Society.
India assesses if patent laws would violate TRIPS
A committee appointed by the Indian government has submitted a report into whether patent issues around microorganisms and NCEs are in compliance with TRIPS.
Plucked hair model could help smooth drug development path
Epistem claims its “plucked hair biomarker model” provides drugmakers with minimally invasive way monitoring epithelial response to cancer candidates that can significantly reduce development times.